OTC Drug Market in India 2012
The report is sent in 0-2 business days after order is placed.
Over-the-counter drug market in India ranks eleventh in the global OTC market and is expected to reach the ninth position within the next five years. Since Indian patients have a huge tendency for self treatment, the Indian market is characterized by a huge demand for OTC drugs. It is a highly fragmented market with a large number of foreign and domestic players. Rising consumer confidence in OTC products, increasing number of shifts from prescription to OTC drugs, increasing focus on brand building, booming retail growth and changing demographics is helping the market to grow. The Indian Government, on its part has taken initiatives to reduce drug prices, has made certain reforms in the tax structure and has undertaken various other initiatives to promote the OTC market. The market is expected to exhibit steady growth over the next few years.
The report begins with the introduction section which offers a brief insight into the major over-the-counter segments. It then moves to the market overview section which provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth. The top ten OTC brands in both the Indian and the global market, along with the sales figures have been provided. The report also provides individual market sizes for the different segments of the OTC market.
An analysis of the drivers explains the factors for growth of the industry including rising consumer confidence in OTC products, increasing number of shifts from prescription to OTC drugs, booming retail growth, increasing focus on brand building, changing demographics and lower price control. The key challenges include low penetration in rural areas, preference of home remedies to OTC products, high competition and time consuming clinical trial procedures
The government initiatives section gives analyses the efforts to reduce drug prices, changes in the customs duty structure and the various other initiatives undertaken by the Government.
A brief overview of the drug market value chain and drug regulations is presented in the next section. It analyses the pharmaceutical value chain, and focuses on the different stages of clinical trial that a drug must pass through. A snapshot of different regulatory frameworks existing in the Indian pharma industry has been shown.
The competition section gives overview of pharmaceutical companies in the country operating in the OTC product industry. Thereafter, the report highlights the features of the major players operating in the market in detail. It includes elaborate profile of the major players in the market along with their financial analysis. Porters Five Forces Analysis has been incorporated for a brief but effective understanding of the market scenario. It also incorporates the recent developments in the OTC drug industry.
The report also includes a section on strategic recommendations created after a thorough analysis of the industry. The strategic recommendations section focuses on some effective strategic decisions which can be taken up by companies to increase their market shares. The OTC market is mainly concentrated in rural parts of the country. There is a huge opportunity lying in the rural market. The increasing education level, per capita disposable income will drive the OTC market. The OTC manufacturers should penetrate in the rural market as well. Companies should also focus towards diversified distribution channels. Brand creation for the OTC products and expansion into several OTC segments can also be effective strategies for the manufacturers to increase their sell figures and market shares.
Over-the-counter drug market in India ranks eleventh in the global OTC market and is expected to reach the ninth position within the next five years. Since Indian patients have a huge tendency for self treatment, the Indian market is characterized by a huge demand for OTC drugs. It is a highly fragmented market with a large number of foreign and domestic players. Rising consumer confidence in OTC products, increasing number of shifts from prescription to OTC drugs, increasing focus on brand building, booming retail growth and changing demographics is helping the market to grow. The Indian Government, on its part has taken initiatives to reduce drug prices, has made certain reforms in the tax structure and has undertaken various other initiatives to promote the OTC market. The market is expected to exhibit steady growth over the next few years.
The report begins with the introduction section which offers a brief insight into the major over-the-counter segments. It then moves to the market overview section which provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth. The top ten OTC brands in both the Indian and the global market, along with the sales figures have been provided. The report also provides individual market sizes for the different segments of the OTC market.
An analysis of the drivers explains the factors for growth of the industry including rising consumer confidence in OTC products, increasing number of shifts from prescription to OTC drugs, booming retail growth, increasing focus on brand building, changing demographics and lower price control. The key challenges include low penetration in rural areas, preference of home remedies to OTC products, high competition and time consuming clinical trial procedures
The government initiatives section gives analyses the efforts to reduce drug prices, changes in the customs duty structure and the various other initiatives undertaken by the Government.
A brief overview of the drug market value chain and drug regulations is presented in the next section. It analyses the pharmaceutical value chain, and focuses on the different stages of clinical trial that a drug must pass through. A snapshot of different regulatory frameworks existing in the Indian pharma industry has been shown.
The competition section gives overview of pharmaceutical companies in the country operating in the OTC product industry. Thereafter, the report highlights the features of the major players operating in the market in detail. It includes elaborate profile of the major players in the market along with their financial analysis. Porters Five Forces Analysis has been incorporated for a brief but effective understanding of the market scenario. It also incorporates the recent developments in the OTC drug industry.
The report also includes a section on strategic recommendations created after a thorough analysis of the industry. The strategic recommendations section focuses on some effective strategic decisions which can be taken up by companies to increase their market shares. The OTC market is mainly concentrated in rural parts of the country. There is a huge opportunity lying in the rural market. The increasing education level, per capita disposable income will drive the OTC market. The OTC manufacturers should penetrate in the rural market as well. Companies should also focus towards diversified distribution channels. Brand creation for the OTC products and expansion into several OTC segments can also be effective strategies for the manufacturers to increase their sell figures and market shares.
Page 1: Executive summary
INTRODUCTION
Page 2: Major OTC segments
MARKET OVERVIEW
Page 3: Global OTC Drug Market – Overview, Size, & Growth (Value Wise: 2010-15e)
Page 4: OTC marketing awards 2011
Page 5: Top 10 global OTC brands 2009
Page 6: Indian OTC Drug Market- Overview, Size & Growth (Value Wise: 2010-2015e)
Page 7: Vitamins & minerals and Gastrointestinals market - Overview, Size & Growth (Value Wise: 2010-2015e)
Page 8: Cough & cold and Analgesics market - Overview, Size & Growth (Value Wise: 2010-2015e)
Page 9: Dermatologicals and Lifestyle OTC market - Overview, Size & Growth (Value Wise: 2010-2015e)
Page 10: Top 10 Indian OTC brands 2009
DRIVERS & CHALLENGES
Page 11: Summary
Page 12-16: Drivers
Page 17-18: Challenges
GOVERNMENT INITIATIVES
Page 19: Summary
Page 20-21: Government Initiatives
MARKET VALUE CHAIN, REGULATION AND PATENTS
Page 22: Pharmaceutical value chain
Page 23: Phases of clinical trials
Page 24: Drug regulations
Page 25: Regulatory frameworks
COMPETITION
Page 26: Market Competition – Porter’s Five Forces Analysis
Page 27: Major Public Companies: Summary
Page 28-67: Major Public Players
Amrutanjan Healthcare Limited
Cipla Limited
Dr. Reddy's Laboratories Limited
GlaxoSmithKline Consumer Healthcare Limited
Lupin Limited
Merck Limited
Novartis India Limited
Nutra Pharma Corporation
Pfizer Limited
Procter & Gamble Hygiene & Health Care Limited
Ranbaxy Laboratories Limited
Page 68: Major Private Companies: Summary%%
Page 69-81: Major private players
Hamdard (Waqf) Laboratories
Johnson and Johnson Limited
Mankind Pharma Limited
Reckitt Benckiser (India) Limited
Page 82: Recent Developments
STRATEGIC RECOMMENDATION
Page 83-84: Strategic Recommendations
APPENDIX
Page 85: Appendix
INTRODUCTION
Page 2: Major OTC segments
MARKET OVERVIEW
Page 3: Global OTC Drug Market – Overview, Size, & Growth (Value Wise: 2010-15e)
Page 4: OTC marketing awards 2011
Page 5: Top 10 global OTC brands 2009
Page 6: Indian OTC Drug Market- Overview, Size & Growth (Value Wise: 2010-2015e)
Page 7: Vitamins & minerals and Gastrointestinals market - Overview, Size & Growth (Value Wise: 2010-2015e)
Page 8: Cough & cold and Analgesics market - Overview, Size & Growth (Value Wise: 2010-2015e)
Page 9: Dermatologicals and Lifestyle OTC market - Overview, Size & Growth (Value Wise: 2010-2015e)
Page 10: Top 10 Indian OTC brands 2009
DRIVERS & CHALLENGES
Page 11: Summary
Page 12-16: Drivers
Page 17-18: Challenges
GOVERNMENT INITIATIVES
Page 19: Summary
Page 20-21: Government Initiatives
MARKET VALUE CHAIN, REGULATION AND PATENTS
Page 22: Pharmaceutical value chain
Page 23: Phases of clinical trials
Page 24: Drug regulations
Page 25: Regulatory frameworks
COMPETITION
Page 26: Market Competition – Porter’s Five Forces Analysis
Page 27: Major Public Companies: Summary
Page 28-67: Major Public Players
Amrutanjan Healthcare Limited
Cipla Limited
Dr. Reddy's Laboratories Limited
GlaxoSmithKline Consumer Healthcare Limited
Lupin Limited
Merck Limited
Novartis India Limited
Nutra Pharma Corporation
Pfizer Limited
Procter & Gamble Hygiene & Health Care Limited
Ranbaxy Laboratories Limited
Page 68: Major Private Companies: Summary%%
Page 69-81: Major private players
Hamdard (Waqf) Laboratories
Johnson and Johnson Limited
Mankind Pharma Limited
Reckitt Benckiser (India) Limited
Page 82: Recent Developments
STRATEGIC RECOMMENDATION
Page 83-84: Strategic Recommendations
APPENDIX
Page 85: Appendix
